Biomea Fusion BMEA
NASDAQ BMEA
$1.76 +0.05 (+2.92%)
As of: Sep 22, 2026 · 11:19 AM EDT

Biomea Fusion (BMEA) Change in Accured Expenses (2020 - 2026)

Biomea Fusion's (BMEA) quarterly Change in Accured Expenses came in at $2.9 million in Q2 2026, up 205.31% year-over-year from $936110.5 in Q2 2025, and up 196.39% quarter-over-quarter from -$3.0 million in Q1 2026.

Analysis

Biomea Fusion (BMEA) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Biomea Fusion has disclosed Change in Accured Expenses across 7 years of filings, most recently posting $2.9 million for Q2 2026.

  • In Q2 2026, Change in Accured Expenses rose 205.31% year-over-year to $2.9 million; the TTM figure through Jun 2026 stood at -$1.7 million (up 79.32% YoY), while the FY2025 annual figure was -$255000.0, up 96.29% from the prior year.
  • Change in Accured Expenses came in at $2.9 million for Q2 2026 at Biomea Fusion, up from -$3.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $4.0 million in Q3 2022 to a low of -$9.2 million in Q4 2024.
  • Average Change in Accured Expenses over 5 years is $197611.1, with a median of $832500.0 recorded in 2022.
  • The largest YoY upside for Change in Accured Expenses was 566.1% in 2024 against a maximum downside of 375.39% in 2024.
  • Over 5 years, Change in Accured Expenses stood at $1.3 million in 2022, then soared by 164.98% to $3.4 million in 2023, then sank by 375.39% to -$9.2 million in 2024, then surged by 78.73% to -$2.0 million in 2025, then soared by 245.59% to $2.9 million in 2026.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were $2.9 million in Q2 2026, -$3.0 million in Q1 2026, and -$2.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 2.32 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 1.20 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 360.00 Mn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - 55.78 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 212.44 Mn
10 Biomea Fusion 132.65 Mn 132.65 Mn - 2.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.86 Mn
Mar 31, 2026 -2.97 Mn
Dec 31, 2025 -1.96 Mn
Sep 30, 2025 400,000.00
Jun 30, 2025 -2.71 Mn
Mar 31, 2025 4.02 Mn
Dec 31, 2024 -9.23 Mn
Sep 30, 2024 -153,000.00
Jun 30, 2024 -1.33 Mn
Mar 31, 2024 3.84 Mn
Dec 31, 2023 3.35 Mn
Sep 30, 2023 2.71 Mn
Jun 30, 2023 -3.35 Mn
Mar 31, 2023 -823,000.00
Dec 31, 2022 1.27 Mn
Sep 30, 2022 4.03 Mn
Jun 30, 2022 1.50 Mn
Mar 31, 2022 2.12 Mn
Dec 31, 2021 -1.10 Mn
Sep 30, 2021 946,000.00
API Access

Biomea Fusion Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BMEA&period=max&api_key=YOUR_API_KEY